Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
03 Feb 2014 Analysis of Somatic Point Mutations in Exome Sequences Translational research
29 Jan 2014 Analysis of Role of Different Genetic Variants Involved in Lynch Syndrome Cancer prevention
29 Jan 2014 European Medicines Agency Recommended Marketing Authorisation for 16 Medicines for the Treatment of Cancer in 2013 Anticancer agents & Biologic therapy
27 Jan 2014 European Medicines Agency Recommends Refusal of the Marketing Authorisation for Masitinib Gastrointestinal cancers - Anticancer agents & Biologic therapy
23 Jan 2014 Risk/Benefit Ratio of New Immunotherapy Strategies Immuno-oncology
22 Jan 2014 Ramucirumab in Combination With Paclitaxel Improves Overall Survival in Second Line Treatment for Metastatic Gastric Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
22 Jan 2014 KRAS Profiling in Non-Squamous NSCLC Translational research - Lung and other thoracic tumours
21 Jan 2014 Phase II Trial Results of Bevacizumab in Combination With Radiotherapy and Cisplatin in Locally-Advanced Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
20 Jan 2014 Vemurafenib in Hairy-Cell Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
16 Jan 2014 Current Therapeutic Options and Development strategies in Cancer Immunotherapy Immuno-oncology
13 Jan 2014 FDA Approves Trametinib in Combination with Dabrafenib for Advanced Melanoma Melanoma - Anticancer agents & Biologic therapy
13 Jan 2014 The Impact of Personalised Medicine in Elderly Patients with Cancer Personalised medicine - Cancer in Special Situations
08 Jan 2014 Personalised Medicine in Melanoma Personalised medicine - Melanoma
06 Jan 2014 Biologicals in the Treatment of Haematological Malignancies Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jan 2014 Personalised Medicine in Carcinoma of Unknown Primary Personalised medicine - Carcinoma of unknown primary site